Akanda Corp(AKAN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 24 at 7:58 PM ET (Korea 9/25 08:58)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -145.41 | Insider Own | 31.16% | Shs Outstand | 0.8M | Perf Week | 6.46% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.5M | Perf Month | -36.77% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 0.03% | Short Float | 7.07% | Perf Quarter | -78.97% |
| Income | -0.05B | P/S | 9.44 | EPS this Y | - | Inst Trans | -75.5% | Short Ratio | 0.03 | Perf Half Y | -12% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -654.33% | Short Interest | 0.04M | Perf YTD | -69.58% |
| Book/sh | -23.86 | P/C | 4.91 | EPS past 3/5Y | 68.73% 31.61% | ROE | -62.26% | 52W High | -98.5% ($209.02) | Perf Year | -96.77% |
| Cash/sh | 0.64 | P/FCF | - | Sales past 3/5Y | -53.82% 162.72% | ROIC | -3843.99% | 52W Low | 36.38% ($2.30) | Perf 3Y | -99.91% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 43.01% | Gross Margin | -382.68% | Volatility(W/M) | 13.51% 12.9% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 57.64 | Sales Y/Y TTM | -69.15% | Oper. Margin | -2022.32% | ATR (14) | 0.53 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.58 | EPS Q/Q | -78.89% | Profit Margin | -17896.95% | RSI (14) | 38.85 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.58 | Sales Q/Q | -28.24% | SMA20 | -5.32% ($3.31) | Beta | 14.16 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -35.75% ($4.87) | Rel Volume | 0.17 | Prev Close | $3.11 |
| Employees | 8 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -68.47% ($9.93) | Avg Volume(3M) | 1.33M | Price | $3.13 |
| IPO | 2022/3/15 | Option/Short | No/Yes | Trades | 1498 | Volume | 226,913 | Change | 0.64% |
Company
AKAN is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🌿 Akanda () is a micro-cap company that cultivates and distributes medical cannabis while also operating telecommunications infrastructure (cell towers and dark fiber) in Mexico. It supplies medical cannabis grown in Lesotho and Portugal to the medical cannabis markets in the UK and Germany, while expanding its business scope into Mexican cell tower and fiber optic operations through its subsidiary First Towers & Fiber.
Over the past 1 year, on the lower side
99% below its 1-year high.
AKAN has weak earning power
Review management risk carefully before investing
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Holding long would have lost money
Would have changed by -99.9% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 0.0%.
Tap to view numbers
It ranks #4 in the industry
Based on market cap of $2M.
AKAN $2M PER -
TAK $59B PER -
TEVA $47B PER 67.1
HLN $41B PER 19.0
FAQ
What kind of company is AKAN?
AKAN belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of AKAN?
The market cap of AKAN is approximately $2M, ranking 5,826 within its sector.
What is the 52-week high and low for AKAN?
AKAN has recorded a 52-week high of $209.02 and a low of $2.30.
